ANIP – ANI Pharmaceuticals Soars to New High After Drug Acquisitions

ANIP stock is up 20% in early trading Friday

   

ANIP – ANI Pharmaceuticals Soars to New High After Drug Acquisitions

ANIP stock had a great Friday morning that saw shares rise as much as 30% before coming back down after making a major acquisition.

prescription drugs 300x180 ANIP   ANI Pharmaceuticals Soars to New High After Drug AcquisitionsANI Pharmaceuticals (ANIP) announced on Friday that it had acquired 31 generic drugs from Teva Pharmaceuticals (TEVA). ANIP shareholders were very pleased with the purchase as company stock is up 20% and it went up as much as 30% earlier today.

With 7 drugs currently in the market, ANI Pharmaceuticals’ purchase will help it expand its portfolio. The company is paying Teva $12.5 million in cash for the drugs as well as a percentage from gross profits. The company expects to release these medications in the fourth quarter of 2014.


Article printed from InvestorPlace Media, http://investorplace.com/2013/12/anip-ani-pharmaceuticals-teva/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.